| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1085824 | Le Pharmacien Hospitalier | 2009 | 7 Pages |
Abstract
Recent revision of the legal environment for clinical research in France provided an opportunity to review what a hospital needs to carry out clinical trials using a radiopharmaceutical investigational drug. Legal measures concerning radiopharmaceutical investigational drugs are indeed more complex than those of classical clinical trials because of the additional legal provisions governing the use of ionizing radiation. Thus, requirements by the concerned staff (sponsor, pharmacist, person in charge of the nuclear activity) are described here.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
G. El-Deeb, B. Nguon, A. Tibi, N. Rizzo-Padoin,